Company intelligence / Profile preview

Kawsar Biotech

Not specified in sources, Iran

Ownership: Private
Employees: ~70
Development stage: Other

Overview

Kawsar Biotech specializes in commercialized diagnostic kits for genetic diseases, human identification, and related molecular genetics laboratory services. The company has not reported clinical trial results in the traditional drug development sense but has established a strong record of product rollout, international certifications, and technology partnerships[5][1][3].

Therapeutic areas: Women's HealthRare DiseasesOther
Modalities: Diagnostic kitMolecular biology reagent
Industry: Molecular Diagnostics

Partnerships

Exclusive representative of MRC Holland in the region[5][9]

Beyond the preview

Go deeper on Kawsar Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kawsar Biotech.

Explore the full profile